K2bio

As a hybrid Contract Research Organization (CRO) and bioaccelerator facility in Houston, Texas, K2bio provides early-stage life science companies with access to advanced laboratory space and scientific expertise. They bridge the gap between preclinical studies and clinical application by offering both self-directed lab use in their ultramodern bio-accelerator facility and full-service contract research options with their experienced scientists. Their turnkey services include GLP/non-GLP in vivo/in vitro studies, process/analytical development under cGMP standards, regulatory consulting (QA/CMC), and vivarium services for animal studies (including an on-site rodent vivarium). The company does not have its own drug pipeline but enables clients to advance their programs toward commercialization and provides operational support.